We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00230256
First Posted: September 30, 2005
Last Update Posted: July 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Stanford University
  Purpose
The purpose of the research study is to evaluate effectiveness and the quality of life, specifically the risk of dry mouth, after radiation treatment for head and neck cancers.

Condition
Head and Neck Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers

Resource links provided by NLM:


Further study details as provided by Stanford University:

Enrollment: 61
Study Start Date: April 2003
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who complete radiation therapy for H&N cancers at Stanford University
Criteria
Inclusion Criteria:Patients who complete radiation therapy for H&N cancers at Stanford University
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00230256


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00230256     History of Changes
Other Study ID Numbers: ENT0003
ENT0003 ( Other Identifier: Stanford University )
79057 ( Other Identifier: Stanford University Secondary IRB Approval Number )
First Submitted: September 28, 2005
First Posted: September 30, 2005
Last Update Posted: July 12, 2012
Last Verified: July 2012

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms